- Min.Order :1 Gram
- Purity: 99%
- Payment Terms : L/C,D/A,D/P,T/T,Other
Keywords
LY3298176 tirzepatide GLP1/GIP
Quick Details
- Appearance:White powder
- Application:
- PackAge:BOTTLE
- ProductionCapacity:100|Kilogram|Year
- Storage:-20℃
- Transportation:
Details:
Tirzepatide Sodium Overview
Tirzepatide sodium, a peptide for treating type 2 diabetes, functions by mimicking the effects of incretin hormones GLP-1 and GIP. These hormones stimulate insulin release, reduce glucagon secretion, and slow gastric emptying. Used for improving blood sugar control in adults with type 2 diabetes, Tirzepatide also aids in weight loss. Administered via subcutaneous injection, it represents a significant advancement in type 2 diabetes management with its dual-action mechanism.
Product Details
- Amino Acid Sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS
- Note: Aib is a non-coded (non-proteinogenic) amino acid – H?H-C(CH?)?-COOH
- Molecular Formula: C???H???N??O??
- Molecular Weight: 4813.527 g/mol
- PubChem CID: 156588324
- CAS Number: 2023788-19-2
Research Highlights
- Blood Glucose Control: Tirzepatide effectively regulates blood glucose levels through dual agonism of GIP and GLP-1 receptors, crucial for insulin secretion and post-meal blood sugar management.
- Cardiovascular Benefits: Demonstrates the ability to improve cardiovascular health by lowering blood pressure and reducing levels of LDL cholesterol and triglycerides, suggesting a broader role in metabolic health beyond diabetes control.
- Important Notices:
- This product is sold for scientific research purposes only.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View